share_log

Reflect Scientific Inc. Addresses Rescheduled Freezer Shipment for a $40B BioPharma Company

Reflect Scientific Inc. Addresses Rescheduled Freezer Shipment for a $40B BioPharma Company

Reflect Scientific Inc. 解决了一家价值400亿美元的生物制药公司重新安排的冷冻柜发货事宜
GlobeNewswire ·  02/07 08:00

OREM, Utah, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in the development of ultra-low temperature storage solutions, today provided an update on the previously announced landmark order from a premier BioPharma company, valued at over $500,000. This notable agreement, the most significant single order in the Company's history, involves supplying our cutting-edge storage freezers to a BioPharma entity with a market capitalization of $40 billion.

犹他州奥勒姆,2024年2月7日(GLOBE NEWSWIRE)——超低温存储解决方案开发领域的领导者Reflect Scientific, Inc.(代码:RSCF)今天提供了有关一家顶级生物制药公司先前宣布的价值超过50万美元的具有里程碑意义的订单的最新情况。这项值得注意的协议是公司历史上最重要的单一订单,涉及向一家市值为400亿美元的生物制药实体提供我们的尖端储存冰柜。

Due to a short delay in the completion of a new facility for the customer, the delivery of the freezer shipment, initially scheduled for the end of the fourth quarter in 2023, has been rescheduled to the early second quarter of 2024. Reflect Scientific Inc. is committed to accommodating the needs of our clients while ensuring the delivery of our high-quality products within the newly agreed timeframe.

由于客户新设施的完工出现短暂延迟,原定于2023年第四季度末交付的冷冻机已改期至2024年第二季度初。Reflect Scientific Inc. 致力于满足客户的需求,同时确保在新约定的时间范围内交付我们的高质量产品。

Mr. Kim Boyce, CEO of Reflect Scientific Inc., stated, "Our dedication to meeting our clients' requirements, even in the face of scheduling adjustments, is paramount. We understand the complexities of our industry and are flexible in our approach to support our clients' success. This order exemplifies our commitment to providing top-tier cold storage solutions and reinforces our capability to manage and adapt to the dynamic needs of the BioPharma sector."

Reflect Scientific Inc. 首席执行官金·博伊斯表示:“即使面对日程调整,我们也致力于满足客户的要求至关重要。我们了解行业的复杂性,并灵活地支持客户取得成功。该订单体现了我们对提供顶级冷库解决方案的承诺,并增强了我们管理和适应生物制药行业动态需求的能力。”

Reflect Scientific Inc. continues to engage in discussions for several other contracts, with shipments slated for 2024, as part of our growth strategy and ongoing commitment to the BioPharma industry. We appreciate the continued trust and cooperation of our valued partners and remain focused on delivering innovative solutions that meet the critical storage needs of the BioPharma industry.

作为我们增长战略和对生物制药行业的持续承诺的一部分,Reflect Scientific Inc.继续讨论其他几份合同,定于2024年发货。我们感谢我们重要合作伙伴的持续信任与合作,并将继续专注于提供满足生物制药行业关键存储需求的创新解决方案。

About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn .

Reflect Scientific, Inc
Reflect Scientific, Inc. 总部位于犹他州奥勒姆,为生物技术、制药、医疗和运输市场开发和销售创新的低温冷却专有技术。Reflect Scientific的产品包括用于实验室、运输和计算机服务器机房的低温冰柜和冷藏系统。参观 反射科学.com 以获取更多信息。在推特 @ReflectSci 和 LinkedIn 上见我们 。

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol "RSCF" and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading "Disclosure," including those identified in such filings as "forward-looking statements."

前瞻性陈述
本新闻稿包含经修订的1933年《证券法》第27A条和经修订的1934年《证券交易法》第21E条所指的前瞻性陈述。前瞻性陈述不能保证未来的业绩或业绩,也不一定能准确表明在何时或之前实现此类业绩或业绩。前瞻性陈述基于发表声明时获得的信息,涉及已知和未知的风险、不确定性和其他因素,这些因素可能导致我们的业绩、活动水平、业绩或成就与本新闻稿中前瞻性陈述所表达或暗示的信息存在重大差异。本新闻稿应根据场外交易市场集团有限责任公司交易代码为 “RSCF” 的公司文件中包含的披露内容以及其中引用并载于美国证券交易委员会埃德加档案中 “披露” 标题下的公司先前相关文件中的披露,包括此类文件中列为 “前瞻性陈述” 的披露。

CONTACT: Contact Investor Relations 801-607-1039 investor_relations@reflectscientific.com
联系人:联系投资者关系部 801-607-1039 investor_relations@reflectscientific.com

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发